GlassScriptPhysician profile
Richard W Knapp
NPI 1134407018
$15,983.71
in general payments reported to CMS, 2019-2025
40 companies · $865 in 2025
The $865 reported for 2025 was more than what 90% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,110 · 2020: $6,083 · 2021: $1,231 · 2022: $1,226 · 2023: $1,320 · 2024: $1,148 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,332.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $10,511.48 | 2019-2024 | Sublocade |
| Novo Nordisk INC | $1,016.04 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $790.50 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $684.26 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $398.13 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $291.95 | 2021-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $251.67 | 2021-2024 | |
| Glaxosmithkline, LLC. | $237.08 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Abbott Laboratories | $229.86 | 2021-2025 | Freestyle Libre 2 |
| Lilly USA, LLC | $224.66 | 2021-2025 | Jardiance, Mounjaro, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.57 | 2021-2022 | |
| Zynex Medical, INC. | $148.06 | 2025 | Nexwave |
| Amgen INC. | $99.22 | 2021-2024 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $79.42 | 2023-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Takeda Pharmaceuticals U.S.A., INC. | $79.40 | 2021-2025 | Entyvio |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Knapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.